Worth reading
55In focus
Scored from 2 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
17000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Report on the Exercise Status of the Third Series Stock Acquisition Rights with Exercise Price Adjustment Clause
発行・処分する株式数
17,000 new shares (0 transferred treasury shares)
発行済株式総数
17,000 new shares, equivalent to approximately 0.69% of the 2,466,320 shares issued
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
Subject to an exercise price adjustment clause. The exercise price during the period ranged from ¥2,380 to ¥2,529 per share. The lower limit of the adjustment is Not disclosed.
Number of Stock Acquisition Rights
Total issued: 1,650 rights; unexercised at the end of the previous month: 1,460 rights; currently unexercised: 1,290 rights
Most recent equity financing
Timing 6 July 2026 / Type Issuance of Series 3 stock acquisition rights / Amount Not disclosed
| Item | Details |
|---|---|
| Type of issuance or disposal | Report on the Exercise Status of the Third Series Stock Acquisition Rights with Exercise Price Adjustment Clause |
| Number of shares to be issued or disposed of | 17,000 new shares (0 transferred treasury shares) |
| Dilution Rate | 17,000 new shares, equivalent to approximately 0.69% of the 2,466,320 shares issued |
| Total number of issued shares | 2,466,320 shares (as of the end of the month preceding the target month) → Not disclosed |
| Exercise price | Subject to an exercise price adjustment clause. The exercise price during the period ranged from ¥2,380 to ¥2,529 per share. The lower limit of the adjustment is Not disclosed. |
| Number of Stock Acquisition Rights | Total issued: 1,650 rights; unexercised at the end of the previous month: 1,460 rights; currently unexercised: 1,290 rights |
| Most recent equity financing | Timing 6 July 2026 / Type Issuance of Series 3 stock acquisition rights / Amount Not disclosed |
Items this document does not state (21)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allotteeIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the large-scale exercise from 1 September 2026 through 24 September 2026 of the Third Series Stock Acquisition Rights issued on 6 July 2026.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.